GSK relief rally after Zantac court decision

GSK relief rally after Zantac court decision

GlaxoSmithKline (GSK), Sanofi and Pfizer have been handed a victory in their defence of thousands of lawsuits claiming that Zantac, the popular drug initially released to treat heartburn, causes cancer.

The court case was brought by plaintiffs who were told that their allegations were based on flawed science, and that the only reliable testing of the blockbuster drug undertaken showed an “unprovable risk of cancer”.

You might like

© 2022 Stockmark.it The Latest StockMarket News and Interviews